Related Experiment Video
Updated: Nov 25, 2025

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
A Blueprint for Identifying Phenotypes and Drug Targets in Complex Disorders with Empirical Dynamics
Madison S Krieger1, Joshua M Moreau2, Haiyu Zhang3
1Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA.
This study uses empirical dynamics to uncover causal mechanisms in cyclic thrombocytopenia, identifying a rare phenotype and validating a new intervention strategy for complex blood disorders.
Area of Science:
- Hematology
- Systems Biology
- Computational Medicine
Background:
- Translating observational findings to mechanistic understanding is crucial for advancing medical treatments and identifying novel phenotypes.
- Cyclic thrombocytopenia is characterized by abnormal oscillations in blood cells and proteins, presenting a complex challenge for mechanistic insight.
Purpose of the Study:
- To apply empirical dynamics, a model-free approach, to infer mechanistic networks from longitudinal data in cyclic thrombocytopenia.
- To investigate a potential rare phenotype within cyclic thrombocytopenia and explore its underlying causes.
- To simulate and evaluate the efficacy of an intervention strategy for this disorder.
Main Methods:
- Utilized empirical dynamics, a set of mathematical techniques, to analyze longitudinal data from three subjects with cyclic thrombocytopenia.
- Performed model-free inference of mechanistic networks to understand the dynamics of cellular and protein oscillations.
- Simulated an intervention based on the inferred network to assess its therapeutic potential.
Main Results:
- The analyses supported the identification of a rare phenotype in one subject with atypical markers for cyclic thrombocytopenia.
- New evidence was provided for a theoretical cause of the disorder.
- Simulations of an intervention demonstrated encouraging results, even when applied to external patient data.
Conclusions:
- Empirical dynamics can successfully infer mechanistic networks from longitudinal data in complex hematological disorders.
- The study identified a rare phenotype of cyclic thrombocytopenia and provided insights into its etiology.
- The validated intervention strategy shows promise for broader applicability in treating complex disorders.
More Related Videos
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis of Population Pharmacokinetic Data
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

